GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹9,882 Cr | ₹8,799 Cr | ₹7,870 Cr | ₹9,457 Cr | ₹9,211 Cr |
What is the latest Profit & Loss Account Balance ratio of GLENMARK PHARMACEUTICALS ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹9,882 Cr |
| Mar2025 | ₹8,799 Cr |
| Mar2024 | ₹7,870 Cr |
| Mar2023 | ₹9,457 Cr |
| Mar2022 | ₹9,211 Cr |
How is Profit & Loss Account Balance of GLENMARK PHARMACEUTICALS Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹9,882 Cr | 12.31 | |
| Mar2025 | ₹8,799 Cr | 11.79 | |
| Mar2024 | ₹7,870 Cr | -16.78 | |
| Mar2023 | ₹9,457 Cr | 2.67 | |
| Mar2022 | ₹9,211 Cr | - | |
Compare Profit & Loss Account Balance of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹65,930.4 Cr | -2% | -5.2% | 13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -2% |
-5.2% |
13.7% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses